A recent prospective study by He et al. (61) also looked at complement activation in preeclampsia across the course of pregnancy with evidence that dysregulation of the classical and alternative pathways occurred as early as the first trimester in preeclampsia, and alterations in C3a and C5a were evident throughout. The gene discussed is C5; the disease is preeclampsia.